SSSergio A. Segrera

Sergio A. Segrera

*This is an algorithmically generated author record based on publicly available information.

Sergio A. Segrera has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chapter 9: The Effect of Rituximab-Based Induction on Lymphocyte Subset Recovery in Vascularized Composite Allotransplantation

    by Hailey P. Wyatt, Alexis K. Gursky, Sergio A. Segrera, Anandhini D. Narayanan, Anabel R. Miller, Jason M. Harris, Bruce E. Gelb, Daniel J. Ceradini, Eduardo D. Rodriguez

    Vascularized composite allotransplantation (VCA) restores form and function in patients with severe disfigurement, but long-term success remains limited by acute rejection (AR). Most induction protocols emphasize T-cell depletion with antithymocyte globulin (ATG) and corticosteroids. Given the immunogenicity of skin-containing allografts and growing recognition of B-cell contributions to alloimmunity, our institution incorporated rituximab, a CD20-directed monoclonal antibody, into induction therapy. We characterized B- and T-cell reconstitution through the first episode of AR in 4 VCA recipients transplanted at a single institution, all of whom underwent induction with rituximab, ATG, and methylprednisolone, followed by maintenance therapy with tacrolimus, mycophenolate mofetil, and prednisone. Serial peripheral blood samples were analyzed by flow cytometry for absolute counts of CD3+ T cells and CD19+ B cells. All recipients demonstrated near-complete CD19+ B-cell depletion after induction. In Patients 1 to 3, CD19+ counts remained suppressed for ∼200 days; these patients subsequently experienced their first AR on postoperative day (POD) 914, 536, and 282, respectively. Patient 4 demonstrated rapid depletion and persistent suppression of CD19+, remaining rejection-free throughout follow-up. In contrast, CD3+ reconstitution was heterogeneous: Patients 1 and 2 demonstrated gradual recovery, Patient 3 had marked fluctuations, and Patient 4 exhibited persistent suppression. Rituximab-based induction produced durable B-cell depletion across all recipients, while T-cell recovery was heterogeneous and appeared temporally associated with rejection. The absence of rejection in the single recipient with persistently low CD3+ and CD19+ counts suggests that delayed global immune reconstitution may contribute to prolonged graft stability. These observations support longitudinal monitoring of lymphocytes and warrant validation in larger cohorts.

  • Chapter 6-Teamwork in Vascularized Composite Allotransplantation: The Role of Multidisciplinary Collaboration and Rehearsal

    by Anabel R. Miller, Jason M. Harris, Anandhini D. Narayanan, Sergio A. Segrera, Bruce E. Gelb, Daniel J. Ceradini, G. Leslie Bernstein, Eduardo D. Rodriguez

    Vascularized composite allotransplantation (VCA) is among the most technically and logistically complex procedures in reconstructive surgery. VCA requires multiple highly specialized teams to coordinate simultaneously throughout an intricate, time-sensitive operation, making effective communication, trust, and coordination essential to patient safety and clinical outcomes. These teams span numerous disciplines, including plastic surgery, anesthesiology, psychiatry, critical care, medical ethics, nursing, perioperative services, radiology, social work, and transplant immunology. A successful transplant depends on the ability of these specialties to function as a cohesive unit. At New York University, multidisciplinary planning, cadaveric rehearsals, procedural checklists, and structured debriefings are used to integrate specialties into a collaborative team before transplantation. Rehearsals allow the team to refine technical approaches, identify potential challenges, and clarify roles and expectations, while fostering trust and effective communication. The value of this approach was demonstrated during the preparation of the first combined full-face and bilateral hand transplant. Across 11 cadaveric rehearsals, Clinical Teamwork Scales improved with repeated practice, including significant gains in communication and situational awareness. These improvements were accompanied by increased operative efficiency. This experience demonstrates that a multidisciplinary VCA team is not inherently effective by virtue of its composition. Successful VCA teams are built deliberately through shared preparation and repeated practice, transforming specialized individual expertise into coordinated achievement of a common operative goal.

  • Chapter 5-Belatacept for Durable Control of Recurrent Acute Rejection in Vascularized Composite Allotransplantation: A Combined Face and Bilateral Hand Transplant Patient Report

    by Anandhini D. Narayanan, Sergio A. Segrera, Anabel R. Miller, Jason M. Harris, Bruce E. Gelb, Daniel J. Ceradini, Eduardo D. Rodriguez

    Vascularized composite allotransplantation carries a persistently high burden of acute rejection, and standardized strategies for treatment-refractory disease remain undefined. The authors report the course of a combined face and bilateral hand transplant recipient, transplanted for sequelae of an 80% total body surface area burn, who experienced 11 episodes of acute rejection over ∼4 years despite standard triple immunosuppression and sequential adjunctive therapy with sirolimus and everolimus. Eight episodes were cellular, and 3 met criteria for antibody-mediated rejection on the basis of elevated angiotensin II type 1 receptor (AT1R) antibody rather than donor-specific antibody, which remained undetectable throughout the patient’s course. After exhausting conventional adjuncts, belatacept was added to continued calcineurin-inhibitor therapy. Over the subsequent 26 months, 4 confirmed rejection episodes occurred within the first 9 months, overlapping the loading phase and everolimus withdrawal; no episode thereafter required plasmapheresis, thymoglobulin, or rituximab, and 2 later presentations were ultimately classified as inflammatory rather than confirmed rejection. Simultaneous biopsies of the hand and facial allograft components showed discordant Banff grades, and dermal sclerosis was a recurring histologic finding across the treatment course. Renal function remained stable despite continued calcineurin-inhibitor exposure, and Epstein-Barr virus DNA remained undetectable on serial surveillance despite a donor-positive, recipient-negative serostatus mismatch. This case, among the longer-reported courses of adjunctive belatacept in this population, suggests that costimulation blockade, added to ongoing calcineurin-inhibitor therapy, may reduce the severity and treatment intensity of recurrent rejection in a previously treatment-refractory vascularized composite allograft recipient.

  • Chapter 3-Three Decades of Vascularized Composite Allotransplantation: OPTN Registry Characteristics and Acute Rejection Outcomes in Skin-Containing Grafts

    by Anandhini D. Narayanan, Sergio A. Segrera, Anabel R. Miller, Jason M. Harris, Bruce E. Gelb, Daniel J. Ceradini, Eduardo D. Rodriguez

    Vascularized composite allotransplantation (VCA) literature has been constrained by incomplete registry reporting, and acute rejection (AR) in skin-containing grafts remains poorly characterized despite its clinical importance. The authors performed a retrospective cohort study using OPTN VCA transplant and follow-up data sets, encompassing the complete available registry history (1998–2025) rather than restricting to the postoversight window used in prior OPTN/SRTR reports. Baseline characteristics were summarized for all 152 VCA recipients (64 uterus, 88 nonuterus), and AR burden, timing, and baseline correlates were analyzed among 87 nonuterus, skin-containing recipients using univariable Cox regression and log-rank testing. Nonuterus transplant activity extended back to 1998, well before formal OPTN oversight began in 2014, and data completeness varied substantially by variable, organ subtype, and era; several key fields, including donor age, diagnosis, race/ethnicity, and blood type, were disproportionately missing among the earliest nonuterus recipients. Among skin-containing recipients with follow-up, 56.5% experienced at least 1 AR episode, with a median time to first rejection of 25 days and frequent recurrence (median 5 episodes per rejector). Rejection incidence and timing varied by graft type, and a higher baseline calculated panel-reactive antibody (cPRA) was associated with earlier first rejection (HR=1.015, P =0.024). These findings demonstrate that the US VCA outcomes are shaped by both heterogeneous, graft-type-specific rejection burden and longstanding gaps in registry reporting. Meaningful comparison across VCA subtypes will require standardized definitions, mandatory reporting, and systematic longitudinal follow-up, particularly for rejection-related and immunologic variables.

  • Chapter 7-Long-Term Skeletal Stability in Face Transplantation: A Longitudinal CT Surface Deviation Analysis

    by Sergio A. Segrera, Anandhini D. Narayanan, Anabel R. Miller, Jason M. Harris, Bruce E. Gelb, Daniel J. Ceradini, Eduardo D. Rodriguez

    Bone-containing facial vascularized composite allotransplantation (VCA) requires precise skeletal reconstruction to restore facial projection, occlusion, orbital support, and the face's structural framework. Virtual surgical planning (VSP) and patient-specific surgical devices facilitate donor-recipient skeletal alignment, but long-term maintenance of the planned skeletal relationships has not been well quantified. We performed a retrospective longitudinal analysis of surface deviations on computed tomography (CT) images in 3 facial VCA recipients with osseous allograft components. For each recipient, early and delayed postoperative CT scans were compared with the final VSP using PROPLAN CMF. The primary outcomes were changes in surface agreement within ±1 mm for upper skull/midface and full mandible; additional skeletal subunits were evaluated as secondary outcomes. Early imaging was obtained at a mean of 23.7 days post-transplantation (range: 2–52 d), and delayed imaging at a mean of 3.12 years (range: 2.02–5.27 y). The mean upper skull/midface agreement was 86.0% at early and 83.0% at delayed follow-up, corresponding to a mean change of −3.0 percentage points (range: −7 to −1). The mean mandibular agreement increased from 50.0% to 57.7%, a mean change of +7.7 percentage points (range: −1 to +13). Secondary regional analyses demonstrated greater heterogeneity among individual skeletal subunits. These findings demonstrate sustained longitudinal concordance between postoperative skeletal position and the original VSP over multiyear follow-up. VSP provides both a reproducible framework for precise osseous reconstruction and a durable reference for longitudinal assessment of skeletal outcomes after facial VCA. Standardized regions of interest and serial imaging protocols will be important for future comparisons across recipients and centers.

  • Chapter 8-Standardizing Postoperative Outcome Assessment After Face Transplantation: A Proposed Core Assessment Framework

    by Sergio A. Segrera, Anandhini D. Narayanan, Anabel R. Miller, Jason M. Harris, Bruce E. Gelb, Daniel J. Ceradini, Eduardo D. Rodriguez

    Outcome assessment after face transplantation remains heterogeneous, limiting comparison of recovery, patient benefit, and treatment burden across programs. We sought to define a face-specific core outcome set for longitudinal postoperative assessment, informed by the NYU Langone experience and its published outcome literature. We performed a methodological inventory of postoperative assessments used across 4 NYU Langone face transplant recipients treated between 2015 and 2023 and reviewed face-relevant peer-reviewed publications available through September 2026. Recipient-level outcome values were not reanalyzed. Measures were prioritized for clinical relevance, repeatability, and suitability for longitudinal comparison. Twenty-three relevant publications from the NYU program informed the framework. The proposed core outcome set comprises 6 domains: (1) allograft integrity and surgical outcomes; (2) rejection, immunologic surveillance, and immunosuppression-related morbidity; (3) facial sensory and motor recovery; (4) speech, swallowing, and oral function; (5) structural and region-specific facial outcomes; and (6) patient-reported outcomes, rehabilitation, and treatment burden. This face-specific framework provides a clinically focused minimum data set for longitudinal outcome assessment after face transplantation. Consistent use may improve patient tracking and facilitate more meaningful comparison across programs, while prospective multicenter implementation will be necessary to refine and validate the proposed core set.

  • Global Public Perceptions of Vascularized Composite Allotransplantation

    by Claire G. Olivas, Hailey P. Wyatt, Alexis K. Gursky, Neil Menghani, Priyanka Pulvender, Paul Sheriff, Aditya Arkalgud, Anandhini Narayanan, Sergio Segrera, Eduardo D. Rodriguez

    Introduction: Vascularized Composite Allotransplantation (VCA) is a reconstructive technique that restores form and function in patients with severe tissue loss from trauma, burns, tumors, or congenital anomalies. Despite improving clinical outcomes, public understanding and acceptance remain barriers to widespread public acceptance. This systematic review examines global public perceptions of VCA, focusing on demographic, cultural, religious, and educational influences on donation. Methods: A PRISMA-guided systematic review was conducted in June 2025 across PubMed, Embase, MEDLINE, Scopus, and Web of Science. Eligible studies included original surveys or mixed-methods research involving nonexpert participants who reported willingness to donate to VCA. Excluded were studies limited to experts, discussion articles, reviews, abstracts, or commentaries. Results: Twenty studies met the inclusion criteria, representing 19,023 respondents from 8 countries. Overall, there was a lower pooled willingness to donate facial VCA than hand VCA, with pooled willingness estimates of 47.9% and 54.8%, respectively. In contrast, willingness to receive VCA was higher overall, with pooled willingness estimates of 65.6% for facial transplantation and 72.4% for hand transplantation. Religious differences were evident: Christian and agnostic respondents were generally more willing to donate, whereas Muslim respondents were less willing. Racial differences were also noted, with White respondents more likely to donate. In contrast, Black and Asian respondents were less likely to indicate willingness to donate. Conclusions: This systematic review provides the first comprehensive synthesis of global survey data on public perceptions of VCA. Nearly half of the respondents reported willingness to donate, with higher acceptance of hand donation than of face donation. Racial, ethnic, and religious factors shape attitudes, underscoring the need for culturally tailored educational strategies to improve donation acceptance.

  • JoVE Video Dataset

    by Elise Lupon, Sergio A. Segrera, Tanguy Perraudin, Anandhini D. Narayanan, Alexis K. Gursky, Hailey P. Wyatt, Eduardo D. Rodriguez

    Full facial vascularized composite allotransplantation (VCA) offers a reconstructive option for patients with severe facial disfigurement who cannot be treated with conventional methods. This article details a surgical protocol for donor procurement of a full facial allograft, focusing on soft tissue with limited bony harvest restricted to the nasal framework, and emphasizes key anatomical landmarks and technical considerations for safe and efficient harvest. The procedure involves dissection of the entire facial soft tissues while preserving the external carotid artery, internal jugular veins and subsequent thyro-linguofacial, and branches of the facial and maxillary nerves to maximize pedicle length for later neurorrhaphy. The protocol describes systematic exposure of the vascular pedicles at their origin in the neck, subperiosteal elevation of the scalp, identification and division of the supraorbital and infraorbital nerves, and preparation of the facial nerve at its root to achieve optimal length. Strategies to minimize ischemia time and ensure allograft integrity are highlighted. This article provides a comprehensive visual guide to the procurement phase of a full soft tissue face allograft and aims to standardize the technique for research application and surgical training in advanced vascularized composite allotransplantation.

  • Surgical Approach to Full Soft Tissue Face Allograft Procurement for Vascularized Composite Allotransplantation

    by Elise Lupon, Sergio A. Segrera, Tanguy Perraudin, Anandhini D. Narayanan, Alexis K. Gursky, Hailey P. Wyatt, Eduardo D. Rodriguez

    Full facial vascularized composite allotransplantation (VCA) offers a reconstructive option for patients with severe facial disfigurement who cannot be treated with conventional methods. This article details a surgical protocol for donor procurement of a full facial allograft, focusing on soft tissue with limited bony harvest restricted to the nasal framework, and emphasizes key anatomical landmarks and technical considerations for safe and efficient harvest. The procedure involves dissection of the entire facial soft tissues while preserving the external carotid artery, internal jugular veins and subsequent thyro-linguofacial, and branches of the facial and maxillary nerves to maximize pedicle length for later neurorrhaphy. The protocol describes systematic exposure of the vascular pedicles at their origin in the neck, subperiosteal elevation of the scalp, identification and division of the supraorbital and infraorbital nerves, and preparation of the facial nerve at its root to achieve optimal length. Strategies to minimize ischemia time and ensure allograft integrity are highlighted. This article provides a comprehensive visual guide to the procurement phase of a full soft tissue face allograft and aims to standardize the technique for research application and surgical training in advanced vascularized composite allotransplantation.

  • Open Access

    Reshaping Faces, Redefining Risks: A Systematic Review of Orthognathic Surgery Outcomes in Cleft Lip and Palate Patients

    by Sachin R. Chinta, Sergio Segrera, Rebecca Friedman, Alay R. Shah, Rami S. Kantar, Angela S. Volk, David Staffenberg, Eduardo D. Rodriguez

    Background: This study aims to determine a generalized outcome and risk profile for patients undergoing orthognathic surgery for the definitive treatment of cleft lip and palate. Furthermore, we hope to determine the key risk factors that cause increased risk for cleft lip and palate patients undergoing orthognathic surgery. Methods: This study includes a systematic review using PubMed, MEDLINE, Cochrane, and Scopus. Data curation utilized Covidence software, with dual-reviewer screening and conflict resolution by a third party, focusing on publications with the full texts available. Results: The initial search yielded 1697 articles. Following title, abstract, and full-text screening, a total of 62 articles were included in this review. A total of 70.9% of included articles had moderate bias, with the rest having low risk of bias. The sample consisted of 2550 patients with an average age of about 20 years and an average follow-up of 16.8 months. The most employed procedure was Le Fort I osteotomy (99%). In terms of velopharyngeal function, there were notable increases in insufficiency and severity scores, with an average 63% worsening score from the baseline. That being said, patients experienced an average 33% improvement in speech articulation. Furthermore, the average horizontal movement was reported to be 6.09 mm with a subsequent relapse of 0.98 mm overall. Conclusions: This systematic review distills data from 62 articles and 2550 patients. It highlights the efficacy of orthognathic surgery in addressing oropharyngeal and aesthetic deficits. This study identifies relapse and velopharyngeal insufficiency as recurrent complications. These insights inform surgical refinement and patient counseling, laying a foundation for enhanced clinical protocols.